Centric Health

centrichealth.ie

Founded in 2003, Centric Health provides Primary Healthcare GP and Dental Services, Urgent Care, Radiology, Retinal Screening and Occupational Health Services to over 200,000 patients throughout Ireland and the UK each year: Centric Health GP: GP Care is delivered throughout Ireland via an expanding network of purpose-built Primary Care facilities where Centric GP Doctors, Dentists and Nurses work in tandem with Medical Specialists and HSE Primary Care teams (www.centricgp.ie). VHI Swiftcare: In response to long wait times in A & E Hospital departments, Centric Health and VHI formed the VHI Swiftcare Urgent Care network, providing non-life threatening medical care to over 1000 patients a day, 8am to 10pm, 365 days a year.

Related News

INDUSTRIAL IMPACT

PDS BIOTECH ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH THE FDA AND PREPARATION FOR THE REGISTRATIONAL TRIAL

PDS Biotechnology | October 04, 2022

news image

PDS Biotechnology Corporation a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® for the treatment of unresectable, recurrent/metastatic human papilloma virus 16-positive head and neck squamous cell carcinoma. Read More

CELL AND GENE THERAPY

SYSMEX AND THINKCYTE HAVE ENTERED INTO AN AGREEMENT FOR JOINT DEVELOPMENT AND CAPITAL ALLIANCE

Sysmex Corporation | May 17, 2021

news image

Sysmex Corporation and ThinkCyte, Inc. announced today the signing of joint development and investment agreements for the commercialization of an AI-based cell analysis technology in May 2021. The development of novel testing and diagnostic technologies of high clinical utility is being pursued to improve the precision of diagnoses and maximize treatment as healthcare becomes more accurate and personalized at an increased pace - in combination with the advancement of technology. M...

Read More

RESEARCH

TETRASCIENCE R&D DATA CLOUD SELECTED BY LEADING CLINICAL-STAGE BIOTECHNOLOGY COMPANY

TetraScience | September 03, 2021

news image

TetraScience, the R&D Data Cloud company, announced today that Zymeworks Inc. has selected the Tetra Data Platform (TDP) to standardize and automate scientific data flow. As a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics, Zymeworks' R&D engine generates and analyzes large amounts of scientific data in its quest to revolutionize drug design. "In order to take advantage of innovative data sc...

Read More

BAY AREA BIOTECH INCUBATOR OPENS EXTENSIVE NEW LAB FACILITY, PAVING WAY FOR ENTREPRENEURS AND THEIR INNOVATION

MBC BioLabs | May 11, 2020

news image

Innovation and discovery just got easier for life science entrepreneurs as MBC BioLabs announces the opening of a 30,000 square foot building of incubator lab space in San Carlos, Calif.Built specifically as a life-science incubator space over the past 18 months, the new facility brings cutting-edge lab equipment, infrastructure and services to innovators and entrepreneurs so they can begin their discovery work virtually immediately. This is MBC BioLabs' third campus and its seco...

Read More
news image

INDUSTRIAL IMPACT

PDS BIOTECH ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH THE FDA AND PREPARATION FOR THE REGISTRATIONAL TRIAL

PDS Biotechnology | October 04, 2022

PDS Biotechnology Corporation a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® for the treatment of unresectable, recurrent/metastatic human papilloma virus 16-positive head and neck squamous cell carcinoma. Read More

news image

CELL AND GENE THERAPY

SYSMEX AND THINKCYTE HAVE ENTERED INTO AN AGREEMENT FOR JOINT DEVELOPMENT AND CAPITAL ALLIANCE

Sysmex Corporation | May 17, 2021

Sysmex Corporation and ThinkCyte, Inc. announced today the signing of joint development and investment agreements for the commercialization of an AI-based cell analysis technology in May 2021. The development of novel testing and diagnostic technologies of high clinical utility is being pursued to improve the precision of diagnoses and maximize treatment as healthcare becomes more accurate and personalized at an increased pace - in combination with the advancement of technology. M...

Read More
news image

RESEARCH

TETRASCIENCE R&D DATA CLOUD SELECTED BY LEADING CLINICAL-STAGE BIOTECHNOLOGY COMPANY

TetraScience | September 03, 2021

TetraScience, the R&D Data Cloud company, announced today that Zymeworks Inc. has selected the Tetra Data Platform (TDP) to standardize and automate scientific data flow. As a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics, Zymeworks' R&D engine generates and analyzes large amounts of scientific data in its quest to revolutionize drug design. "In order to take advantage of innovative data sc...

Read More
news image

BAY AREA BIOTECH INCUBATOR OPENS EXTENSIVE NEW LAB FACILITY, PAVING WAY FOR ENTREPRENEURS AND THEIR INNOVATION

MBC BioLabs | May 11, 2020

Innovation and discovery just got easier for life science entrepreneurs as MBC BioLabs announces the opening of a 30,000 square foot building of incubator lab space in San Carlos, Calif.Built specifically as a life-science incubator space over the past 18 months, the new facility brings cutting-edge lab equipment, infrastructure and services to innovators and entrepreneurs so they can begin their discovery work virtually immediately. This is MBC BioLabs' third campus and its seco...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us